Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.

Legal Status

Proposed Rule

You may be interested in this older document that published on 12/22/2015 with action 'Proposed rule.' View Document

General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; Withdrawal of Proposed Rule

A Proposed Rule by the Food and Drug Administration on 03/16/2026

• 1.

1.

• Document Details Published Content - Document Details Agencies Department of Health and Human Services Food and Drug Administration Agency/Docket Number Docket No. FDA-2015-N-1765 CFR 21 CFR 878 Document Citation 91 FR 12524 Document Number 2026-05103 Document Type Proposed Rule Pages 12524-12525
  (2 pages) Publication Date 03/16/2026 RIN 0910-AH14 Published Content - Document Details

• PDF Official Content

  • View printed version (PDF) Official Content

• Document Details Published Content - Document Details Agencies Department of Health and Human Services Food and Drug Administration Agency/Docket Number Docket No. FDA-2015-N-1765 CFR 21 CFR 878 Document Citation 91 FR 12524 Document Number 2026-05103 Document Type Proposed Rule Pages 12524-12525
  (2 pages) Publication Date 03/16/2026 RIN 0910-AH14 Published Content - Document Details

• Document Dates Published Content - Document Dates Dates Text The proposed rule published on December 22, 2015 (80 FR 79493) is withdrawn as of March 16, 2026. Published Content - Document Dates

• Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
  headings within the legal text of Federal Register documents.
  This repetition of headings to form internal navigation links
  has no substantive legal effect.

  • AGENCY:
  • ACTION:
  • SUMMARY:
  • DATES:
  • ADDRESSES:
  • FOR FURTHER INFORMATION CONTACT:
  • SUPPLEMENTARY INFORMATION: Enhanced Content - Table of Contents

• Related Documents Enhanced Content - Related Documents FederalRegister.gov uses the agency dockets published with the document to display related documents.

| Docket No. FDA-2015-N-1765
(2 Documents) | | | |
| --- | | | |
| Date | | Action | Title |
| | 2026-03-16 | Proposed rule; withdrawal. | General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; Withdrawal of Proposed Rule |
| | 2015-12-22 | Proposed rule. | General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products |

Enhanced Content - Related Documents

• Public Comments Enhanced Content - Public Comments This feature is not available for this document.

Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data

- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-05103 Email Email this document to a friend Enhanced Content - Sharing

• Print Enhanced Content - Print
  • Print this document Enhanced Content - Print
• Document Statistics Enhanced Content - Document Statistics Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.

Page views 44
as of
03/14/2026 at 2:15 pm EDT Enhanced Content - Document Statistics
- Other Formats Enhanced Content - Other Formats This document is also available in the following formats:

JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-05103 as it appeared on Public Inspection on
03/13/2026 at 8:45 am.

It was viewed
63
times while on Public Inspection.

If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507. Learn more here.

Public Inspection
Published Document: 2026-05103 (91 FR 12524) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings Document headings vary by document type but may contain
the following:

1. the agency or agencies that issued and signed a document
2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
3. the agency docket number / agency internal file number
4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.

Department of Health and Human Services

Food and Drug Administration

1. 21 CFR Part 878
2. [Docket No. FDA-2015-N-1765]
3. RIN 0910-AH14

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule; withdrawal.

SUMMARY:

The Food and Drug Administration (FDA) is announcing the withdrawal of the proposed rule titled “General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products,” which published in the Federal Register of December 22, 2015. FDA is taking this action because it no longer intends to finalize the proposed rule.

DATES:

The proposed rule published on December 22, 2015 (80 FR 79493) is withdrawn as of March 16, 2026.

ADDRESSES:

For access to the docket to read background documents or comments received, go to https://www.regulations.gov and insert the docket number found in brackets in the heading of this document into the “Search” box and follow the prompts, and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT:

Daniel Schieffer, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5562, Silver Spring, MD 20993-0002, 301-796-3350, daniel.schieffer@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

In the Federal Register of December 22, 2015 (80 FR 79493), FDA (the Agency or we) issued a proposed rule titled “General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products” (the Proposed Rule). Sunlamp products are both “devices” under section 201(h)(1) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 321(h)(1)) and “electronic products” under section 531(2) of the FD&C Act (21 U.S.C. 360hh(2)). They are designed to incorporate one or more ultraviolet (UV) lamps intended for irradiation of any part of the living human body, by UV radiation with wavelengths in air between 200 and 400 nanometers, to induce skin tanning (see §§ 878.4635(a) and 1040.20(b)(9) (21 CFR 878.4635(a) and 1040.20(b)(9))). Sunlamp products include tanning beds and tanning booths. Sunlamp products as defined in the Proposed Rule did not include ultraviolet lamps for dermatological disorders regulated under 21 CFR 878.4630.

FDA has undertaken several regulatory initiatives related to sunlamp products. Previously, in a final reclassification order that we issued on June 2, 2014 (79 FR 31205), FDA reclassified sunlamp products and UV lamps intended for use in sunlamp products from class I to class II, making them subject to premarket notification (510(k)) requirements, and established special controls under the device authorities of the FD&C Act. The special controls consist of, among other requirements, performance testing and labeling requirements, including a warning that sunlamp products should not be used on persons under the age of 18 years. That order was effective on September 2, 2014.

Second, in a proposed rule issued simultaneously with the Proposed Rule, FDA proposed amendments to the sunlamp products and UV lamps performance standard at 21 CFR 1040.20, which includes technical and labeling requirements issued in large part under the electronic product radiation control provisions of the FD&C Act (80 FR 79505). Those proposed amendments, if finalized, would update the electronic product performance standard to reflect current science and harmonize with certain consensus standards. FDA's proposed amendments to the sunlamp products and UV lamps performance standard at 21 CFR 1040.20 are not affected by this withdrawal.

Finally, in the Proposed Rule, FDA proposed to establish device restrictions under section 520(e) of the FD&C Act (21 U.S.C. 360j(e)), which authorizes FDA to issue regulations imposing restrictions on the sale, distribution, or use of a device. The Proposed Rule contained three types of proposed restrictions on the use of sunlamp products. First, the Proposed Rule proposed restricting the use of sunlamp products to individuals age 18 and older under proposed § 878.4635(c)(1). Second, in proposed § 878.4635(c)(4), the Proposed Rule proposed requiring ( printed page 12525) tanning facilities to only allow adults to use a sunlamp product if the prospective user had signed a risk acknowledgement certification in the past six months, and proposed the form of this certification. Third, the Proposed Rule contained two proposed user-manual related provisions. In proposed § 878.4635(c)(2), the Proposed Rule proposed requiring tanning facility operators to provide a sunlamp product's user manual to users or prospective users of sunlamp products upon request, and in proposed § 878.4635(c)(3), the Proposed Rule proposed requiring 510(k) holders to provide a sunlamp product's user manual to tanning facility operators and sunlamp product users or prospective users upon request.

FDA received more than 8,100 comments on the Proposed Rule from entities including industry associations, medical and healthcare professional associations, law firms, cancer advocacy groups, and other interested parties, including individuals. In general, the comments discussed the dangers of UV radiation from sunlamp products; scientific aspects of the Proposed Rule; vulnerability of young people to the risks of sunlamp products; support for personal choice and parental decision-making; availability and relative safety of sunlamp product alternatives; and compliance burdens on small businesses.

In light of the scientific and technical concerns raised in the comments on the Proposed Rule, concerns regarding possible unintended consequences of certain proposals in the Proposed Rule, and potential alternatives proposed in comments received on the Proposed Rule, FDA is withdrawing the Proposed Rule in order to reconsider the best means for addressing the issues covered by the Proposed Rule and related issues regarding access to sunlamp products. Therefore, effective on the date of publication of this document, the Proposed Rule is withdrawn.

FDA continues to consider regulatory initiatives related to sunlamp products. The withdrawal of the Proposed Rule does not preclude the Agency from reinstituting rulemaking concerning the issues addressed in the proposal. Should we decide to undertake such rulemaking in the future, we will issue a proposed rule and provide a new opportunity for comment. Furthermore, this withdrawal is only intended to address the Proposed Rule “General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products” published in the Federal Register of December 22, 2015, and not any other pending proposals that the Agency has issued or is considering. If you need additional information about the subject matter of the withdrawn Proposed Rule, you may review the Agency's website (www.fda.gov) for any current information on the matter.

Robert F. Kennedy, Jr.,

Secretary, Department of Health and Human Services.

[FR Doc. 2026-05103 Filed 3-13-26; 8:45 am]

BILLING CODE 4164-01-P

Published Document: 2026-05103 (91 FR 12524)